International Partnership For Microbicides CEO Discusses Research In GlobalPost Interview
GlobalPost’s “Global Pulse” blog features an interview with Zeda Rosenberg, CEO of the International Partnership for Microbicides (IPM), in which she discusses a study of a vaginal ring containing the antiretroviral (ARV) dapivirine. The study, which “has been launched in Africa, mark[s] a step forward in the development of HIV protection for and under control of women,” the blog notes. Rosenberg addresses the importance of finding a female-controlled HIV prevention option, why women are more susceptible to HIV infection, and her motivation for becoming involved in HIV research, among other issues, according to the blog (Judem, 7/18).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.